Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
Year: 2018
Type: article
Source: Leukemia
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: Homologous Recombination Mediates Genomic Instability and Progression in Myeloma, Host-tumor cell interaction in myeloma: therapeutic applications, SPORE in Multiple Myeloma, Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications, Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma, Integrative Oncogenomics of Multiple Myeloma
OpenAlex ID: W2791113648
